Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials

Scheres, L.J.J.; Lijfering, W.M.; Middeldorp, S.; Cheung, Y.W.; Barco, S.; Cannegieter, S.C.; Coppens, M. (2018)

Article / Letter to editor

• apixaban
• blood coagulation tests
• coagulants
• factor Xa inhibitors
• risk assessment
• rivaroxaban

• All authors: Scheres, L.J.J.; Lijfering, W.M.; Middeldorp, S.; Cheung, Y.W.; Barco, S.; Cannegieter, S.C.; Coppens, M.
• Date: 2018-10-31
• Journal: Research and Practice in Thrombosis and Haemostasis
• Volume: 2
• Issue: 4
• Pages: 689 - 695
• DOI: doi:10.1002/rth2.12142
• Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178718/pdf/RTH2-2-689.pdf